Original article

Retrospective study on Bethesda Ⅴ thyroid nodule in diagnosis of papillary thyroid carcinoma: retrospective study

Expand
  • Department of Thyroid and Vascular Surgery, Fujian Medical University Union Hospital, Fujian Fuzhou 350001, China

Received date: 2021-10-08

  Online published: 2022-07-27

Abstract

Objective To study on preoperative diagnosis of papillary thyroid carcinoma (PTC) with Bethesda Ⅴ thyroid nodules retrospectively and to explore the differences of clinical parameters between Bethesda Ⅴ and Ⅵ thyroid nodules. Methods The clinical data of 430 patients were analyzed. Results Univariate analysis showed that there were significant differences of Bethesda Ⅴ nodules in nodule boundary, tumor size and echo between PTC group of 159 cases and benign group of 20 cases (P<0.05). It was shown from multivariate analysis that nodule boundary, tumor size and echo were risk factors for malignant diagnosis of BethesdaⅤnodule. The differences were present significantly in TI-RADS grade, aspect ratio and echo between Bethesda ⅤPTC group of 159 case and Bethesda Ⅵ thyroid nodule group of 251 cases (P<0.05). Further multivariate analysis showed that TI-RADS grade, aspect ratio, relation of nodule with capsule, thyroid peroxidase antibody level and echo were the risk factors for the diagnosis of PTC. Conclusions Bethesda Ⅴ nodules with higher grade of TI-RADS are malignant more possibly and those with lower grade of TI-RADS need to be evaluated such as thyroid nodules sizes, relation of nodules with capsule and thyroid peroxidase antibody level.

Cite this article

YAN Shouyi, CHEN Hongbin, ZHANG Liyong, WANG Bo, CAI Shaojun, LIN Siying, ZHAO Wenxin . Retrospective study on Bethesda Ⅴ thyroid nodule in diagnosis of papillary thyroid carcinoma: retrospective study[J]. Journal of Surgery Concepts & Practice, 2021 , 26(06) : 512 -516 . DOI: 10.16139/j.1007-9610.2021.06.011

References

[1] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[2] 黄万泽, 张哲嘉, 白宁, 等. 超声引导下细针穿刺对甲状腺结节的诊断价值及其影响因素[J]. 中国普通外科杂志, 2019, 28(11):1347-1353.
[3] 张晓芳, 刘志艳. 2018版甲状腺细针穿刺活检细胞病理学Bethesda报告系统解读[J]. 中华病理学杂志, 2018(9):729-732.
[4] Xue E, Zheng M, Zhang S, et al. Ultrasonography-based classification and reporting system for the malignant risk of thyroid nodules[J]. Nippon Med Sch, 2017, 84(3):118-124.
[5] 刘丽云, 张志勇, 胡月明, 等. 甲状腺疾病术中冰冻及石蜡病理诊断结果的对比与分析[J]. 中国实验诊断学, 2018, 22(2):295-298.
[6] 梁羽, 岳林先, 陈琴, 等. Kwak 与ACR(2017)甲状腺影像报告和数据系统(TI-RADS)分类的诊断效能比较: 多中心回顾性研究[J]. 中华超声影像学杂志, 2019, 28(5):419-424.
[7] 张贺香, 胡萍香, 胡业深, 等. TI-RADS分类量化评分在鉴别甲状腺结节良恶性中的应用[J]. 中国中西医结合影像学杂志, 2017, 15(3):300-304.
[8] 姚建锋, 张煜华, 王全江, 等. TI-RADS分类与常规超声在甲状腺结节定性诊断中的诊断效能[J]. 肿瘤学杂志, 2017, 23(4):273-277.
[9] Haugen BR, Alexander EK, Bible KC, et al. 2015 Ame-rican Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
[10] 张帆, 陈文, 薛恒, 等. 纵横比对于不同大小甲状腺乳头状癌的超声诊断价值研究[J]. 中国超声医学杂志, 2020, 36(1):8-10.
[11] Delfim RLC, Veiga LCGD, Vidal APA, et al. Likelihood of malignancy in thyroid nodules according to a proposed Thyroid Imaging Reporting and Data System (TI-RADS) classification merging suspicious and benign ultrasound features[J]. Arch Endocrinol Metab, 2017, 61(3):211-221.
[12] Park VY, Lee HS, Kim EK, et al. Frequencies and malignancy rates of 6-tiered Bethesda categories of thyroid nodules according to ultrasound assessment and nodule size[J]. Head Neck, 2018, 40(9):1947-1954.
[13] Min Y, Huang Y, Wei M, et al. Preoperatively predicting the central lymph node metastasis for papillary thyroid cancer patients with Hashimoto′s thyroiditis[J]. Front Endocrinol (Lausanne), 2021, 12:713475.
[14] 董华, 张遵城, 郭永涛, 等. 甲状腺结节合并桥本氏甲状腺炎与甲状腺癌风险关系的临床研究[J]. 中华内分泌外科杂志, 2018, 12(3):244-246.
[15] 张萌, 滕梁红. 高侵袭性甲状腺乳头状癌亚型研究新进展[J]. 诊断病理学杂志, 2019, 26(1):56-60.
Outlines

/